BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Servagi-Vernat S, Differding S, Sterpin E, Hanin FX, Labar D, Bol A, Lee JA, Grégoire V. Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study. Acta Oncol 2015;54:1008-16. [PMID: 25562382 DOI: 10.3109/0284186X.2014.990109] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Hildingsson S, Gebre-Medhin M, Zschaeck S, Adrian G. Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer - A scoping review. Clin Transl Radiat Oncol 2022;36:40-6. [PMID: 35769424 DOI: 10.1016/j.ctro.2022.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen S, Qin A, Yan D. Dynamic Characteristics and Predictive Capability of Tumor Voxel Dose-Response Assessed Using 18F-FDG PET/CT Imaging Feedback. Front Oncol 2022;12:876861. [PMID: 35875108 DOI: 10.3389/fonc.2022.876861] [Reference Citation Analysis]
3 Gallez B. The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia. Front Pharmacol 2022;13:853568. [DOI: 10.3389/fphar.2022.853568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Qin A, Chen S, Liang J, Snyder M, Yan D. Evaluation of DIR schemes on tumor/organ with progressive shrinkage: accuracy of tumor/organ internal tissue tracking during the radiation treatment. Radiother Oncol 2022:S0167-8140(22)04145-7. [PMID: 35667570 DOI: 10.1016/j.radonc.2022.05.039] [Reference Citation Analysis]
5 Eren G, Kupik O. Necrosis on pre-radiotherapy 18F-FDG PET/CT is a predictor for complete metabolic response in patients with non-small cell lung cancer. Medicine (Baltimore) 2022;101:e29227. [PMID: 35608423 DOI: 10.1097/MD.0000000000029227] [Reference Citation Analysis]
6 Roy A, Dabadghao SS, Marandi A. Value of intermediate imaging in adaptive robust radiotherapy planning to manage radioresistance. Ann Oper Res. [DOI: 10.1007/s10479-022-04699-z] [Reference Citation Analysis]
7 Eraj S, Sher DJ. PET/CT. PET Clinics 2022. [DOI: 10.1016/j.cpet.2021.12.007] [Reference Citation Analysis]
8 Ferini G, Valenti V, Tripoli A, Illari SI, Molino L, Parisi S, Cacciola A, Lillo S, Giuffrida D, Pergolizzi S. Lattice or Oxygen-Guided Radiotherapy: What If They Converge? Possible Future Directions in the Era of Immunotherapy. Cancers (Basel) 2021;13:3290. [PMID: 34209192 DOI: 10.3390/cancers13133290] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
9 Castorina P, Castorina L, Ferini G. Non-Homogeneous Tumor Growth and Its Implications for Radiotherapy: A Phenomenological Approach. J Pers Med 2021;11:527. [PMID: 34207503 DOI: 10.3390/jpm11060527] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
10 Bogowicz M, Pavic M, Riesterer O, Finazzi T, Garcia Schüler H, Holz-Sapra E, Rudofsky L, Basler L, Spaniol M, Ambrusch A, Hüllner M, Guckenberger M, Tanadini-Lang S. Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma - Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes. Front Oncol 2021;11:664304. [PMID: 34123824 DOI: 10.3389/fonc.2021.664304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Huertas A, Kreps S, Giraud P. Radioterapia dei cancri oto-rino-laringoiatrici. EMC - Otorinolaringoiatria 2021;20:1-10. [DOI: 10.1016/s1639-870x(21)44509-5] [Reference Citation Analysis]
12 Huertasa A, Kreps S, Giraud P. Radioterapia de los cánceres otorrinolaringológicos. EMC - Otorrinolaringología 2021;50:1-11. [DOI: 10.1016/s1632-3475(20)44611-9] [Reference Citation Analysis]
13 Akram F, Koh PE, Wang F, Zhou S, Tan SH, Paknezhad M, Park S, Hennedige T, Thng CH, Lee HK, Sommat K. Exploring MRI based radiomics analysis of intratumoral spatial heterogeneity in locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy. PLoS One 2020;15:e0240043. [PMID: 33017440 DOI: 10.1371/journal.pone.0240043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
14 Her EJ, Haworth A, Rowshanfarzad P, Ebert MA. Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview. Cancers (Basel) 2020;12:E854. [PMID: 32244821 DOI: 10.3390/cancers12040854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Morgan HE, Sher DJ. Adaptive radiotherapy for head and neck cancer. Cancers Head Neck. 2020;5:1. [PMID: 31938572 DOI: 10.1186/s41199-019-0046-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 22.5] [Reference Citation Analysis]
16 Campbell A, Davis LM, Wilkinson SK, Hesketh RL. Emerging Functional Imaging Biomarkers of Tumour Responses to Radiotherapy. Cancers (Basel) 2019;11:E131. [PMID: 30678055 DOI: 10.3390/cancers11020131] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
17 Chen X, Mims J, Huang X, Singh N, Motea E, Planchon SM, Beg M, Tsang AW, Porosnicu M, Kemp ML, Boothman DA, Furdui CM. Modulators of Redox Metabolism in Head and Neck Cancer. Antioxid Redox Signal 2018;29:1660-90. [PMID: 29113454 DOI: 10.1089/ars.2017.7423] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
18 Grégoire V, Eriksen J. Impact of hypoxia in head and neck cancer radiotherapy. Clin Transl Imaging 2017;5:497-505. [DOI: 10.1007/s40336-017-0252-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Heukelom J, Lamers E, Slooten E, van Werkhoven E, Rasch C, Sonke J. Redistributed versus homogenous radiotherapy dose for head and neck cancer; a treatment planning study. Physics and Imaging in Radiation Oncology 2017;3:17-20. [DOI: 10.1016/j.phro.2017.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Send T, Kreppel B, Gaertner FC, Bundschuh RA, Strunk H, Bootz F, Essler M. [PET-CT in head and neck cancer]. HNO 2017;65:504-13. [PMID: 28451717 DOI: 10.1007/s00106-017-0355-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
21 Caudell JJ, Torres-Roca JF, Gillies RJ, Enderling H, Kim S, Rishi A, Moros EG, Harrison LB. The future of personalised radiotherapy for head and neck cancer. Lancet Oncol 2017;18:e266-73. [PMID: 28456586 DOI: 10.1016/S1470-2045(17)30252-8] [Cited by in Crossref: 111] [Cited by in F6Publishing: 117] [Article Influence: 22.2] [Reference Citation Analysis]
22 Colliez F, Gallez B, Jordan BF. Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical Settings. Front Oncol 2017;7:10. [PMID: 28180110 DOI: 10.3389/fonc.2017.00010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 10.0] [Reference Citation Analysis]
23 Gladwish A, Han K. Novel Imaging for Treatment Planning or Tumor Response. Cancer Drug Discovery and Development 2017. [DOI: 10.1007/978-3-319-40854-5_9] [Reference Citation Analysis]
24 Cacicedo J, Navarro A, Del Hoyo O, Gomez-Iturriaga A, Alongi F, Medina JA, Elicin O, Skanjeti A, Giammarile F, Bilbao P, Casquero F, de Bari B, Dal Pra A. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist. Br J Radiol 2016;89:20160217. [PMID: 27416996 DOI: 10.1259/bjr.20160217] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
25 Zegers CM, Hoebers FJ, van Elmpt W, Bons JA, Öllers MC, Troost EG, Eekers D, Balmaekers L, Arts-Pechtold M, Mottaghy FM, Lambin P. Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer. Eur J Nucl Med Mol Imaging 2016;43:2139-46. [PMID: 27251643 DOI: 10.1007/s00259-016-3429-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 6.5] [Reference Citation Analysis]
26 Baumann M, Krause M, Overgaard J, Debus J, Bentzen SM, Daartz J, Richter C, Zips D, Bortfeld T. Radiation oncology in the era of precision medicine. Nat Rev Cancer 2016;16:234-49. [PMID: 27009394 DOI: 10.1038/nrc.2016.18] [Cited by in Crossref: 464] [Cited by in F6Publishing: 484] [Article Influence: 77.3] [Reference Citation Analysis]
27 Dabadghao S, Roy A, Wu V. Optimal Interventions for Robust Optimization under Time-Dependent Uncertainty with Application to Radiotherapy. SSRN Journal. [DOI: 10.2139/ssrn.3624421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]